Sanofi SNY
NASDAQ SNY
$41.96 +0.99 (+2.42%)
At close: Oct 22, 2026 · 4:00 PM EDT

Sanofi (SNY) Accumulated Expenses (2018 - 2024)

Updated

Sanofi (SNY) posted Accumulated Expenses of $478.73 million for the quarter ended Dec 31, 2024.

Analysis

Sanofi (SNY) Accumulated Expenses (2018 - 2024) Analysis & Trends

As of Dec 31, 2024, Sanofi's Accumulated Expenses came in at $484.89 million.

  • The figure for the quarter ended Dec 31, 2024 stands as the lowest quarterly Accumulated Expenses since the quarter ended Sep 30, 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Sanofi 50.63 Bn 17.15 Bn 10.79 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 212.29 Mn
Sep 30, 2018 31.42 Mn
API Access

Sanofi Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=SNY&period=max&api_key=YOUR_API_KEY